Mei‐Juan Tu

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 25 papers. Top paper: “RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges”.

RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges

Pharmacological Reviews(2020)10.1124/pr.120.019554

N/A

0DataRank · unranked

401 citations

Young Hee Choi, Mei‐Juan Tu, Ai‐Ming Yu

MicroRNA-1291-5p Sensitizes Pancreatic Carcinoma Cells to Arginine Deprivation and Chemotherapy through the Regulation of Arginolysis and Glycolysis

Molecular Pharmacology(2020)10.1124/molpharm.120.000130

N/A

0DataRank · unranked

36 citations

Zhijian Duan, Zhenzhen Liu, Chao Zhang, Richard J. Bold, Frank J. Gonzalez +3 more

Pharmacokinetic and Pharmacodynamic Factors Contribute to Synergism between Let-7c-5p and 5-Fluorouracil in Inhibiting Hepatocellular Carcinoma Cell Viability

Drug Metabolism and Disposition(2020)10.1124/dmd.120.000207

N/A

0DataRank · unranked

27 citations

Mei‐Juan Tu, Chao Zhang, Ai‐Ming Yu, Joseph L. Jilek

Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination

Pharmacology & Therapeutics(2021)10.1016/j.pharmthera.2021.107967

N/A

0DataRank · unranked

89 citations

Mei‐Juan Tu, Ai‐Ming Yu

Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo

Acta Pharmaceutica Sinica B(2021)10.1016/j.apsb.2021.07.027

N/A

0DataRank · unranked

22 citations

Hannah Petrek, Mei‐Juan Tu, Neelu Batra, Aixi Yu, Ai‐Ming Yu +1 more

Single bioengineered ncRNA molecule for dual-targeting toward the control of non-small cell lung cancer patient-derived xenograft tumor growth

Biochemical Pharmacology(2021)10.1016/j.bcp.2020.114392

N/A

0DataRank · unranked

18 citations

Pui Yan Ho, Neelu Batra, Mei‐Juan Tu, Qianyu Zhang, Jing-Xin Qiu +2 more

A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism

Journal of Pharmacology and Experimental Therapeutics(2021)10.1124/jpet.121.000584

N/A

0DataRank · unranked

16 citations

Chao Zhang, Zhenzhen Liu, Mei‐Juan Tu, Ai-Xi Yu, Ai‐Ming Yu +1 more

Fully‐humanized bioengineered miR‐1291 modulates key nutrient transport and metabolism to exert synergistic anticancer effects with chemotherapeutics

The FASEB Journal(2021)10.1096/fasebj.2021.35.s1.02585

N/A

0DataRank · unranked

1 citations

Zhenzhen Liu, Linglong Deng, Chao Zhang, Ai‐Ming Yu, Mei‐Juan Tu

Bioengineered microRNAs in the control of folate cycle related one‐carbon metabolism in NSCLC metabolism

The FASEB Journal(2021)10.1096/fasebj.2021.35.s1.03377

N/A

0DataRank · unranked

0 citations

Zhenzhen Liu, Mei‐Juan Tu, Neelu Batra, Huichang Bi, YU Ai-ming +1 more

MiR‐124‐3p signaling in the control of metastasis‐related cytoskeleton organization, cell junctions and adhesion

The FASEB Journal(2021)10.1096/fasebj.2021.35.s1.02586

N/A

0DataRank · unranked

0 citations

Hannah Petrek, Mei‐Juan Tu, Ai‐Ming Yu, Linglong Deng

Bioengineered miR‐34a targets MPV17L2 to control cancer cell mitochondrial functions

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r4394

N/A

0DataRank · unranked

0 citations

Wanrong Yi, Aixi Yu, Jun Lin, Ai‐Ming Yu, Mei‐Juan Tu

A novel integrated pharmacokinetic‐pharmacodynamic model for the determination of in vivo synergism of combination therapy

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r3497

N/A

0DataRank · unranked

0 citations

Mei‐Juan Tu, Aiming Yu, Young Hee Choi

Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer

Acta Pharmaceutica Sinica B(2023)10.1016/j.apsb.2023.07.011

N/A

0DataRank · unranked

14 citations

Mei‐Juan Tu, Fangwei Han, Zhenzhen Liu, Neelu Batra, Primo N. Lara +4 more

Recent Advances in Novel Recombinant RNAs for Studying Post-transcriptionalGene Regulation in Drug Metabolism and Disposition

Current Drug Metabolism(2023)10.2174/1389200224666230425232433

N/A

0DataRank · unranked

4 citations

Ai‐Ming Yu, Mei‐Juan Tu

Production, structure, and function analyses of a recombinant miR-1291 agent

Journal of Pharmacology and Experimental Therapeutics(2023)10.1124/jpet.122.259220

N/A

0DataRank · unranked

0 citations

Zhenzhen Liu, Tongyi Dou, Ai‐Ming Yu, Mei‐Juan Tu

Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs

Frontiers in Pharmacology(2024)10.3389/fphar.2024.1423416

N/A

0DataRank · unranked

17 citations

Mei‐Juan Tu, Ai‐Ming Yu, Yimei Wang

Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents

RNA(2024)10.1261/rna.079904.123

N/A

0DataRank · unranked

10 citations

Colleen Yi, Neelu Batra, Mei‐Juan Tu, Ai‐Ming Yu, Gavin M. Traber

Molecular Engineering of Functional SiRNA Agents

ACS Synthetic Biology(2024)10.1021/acssynbio.4c00181

N/A

0DataRank · unranked

7 citations

Mei‐Juan Tu, Ai‐Ming Yu, Neelu Batra

Comparison of Three Computational Tools for the Prediction of RNA Tertiary Structures

Non-Coding RNA(2024)10.3390/ncrna10060055

N/A

0DataRank · unranked

4 citations

Mei‐Juan Tu, Gavin M. Traber, Ai‐Ming Yu, Frank Yiyang Mao

The Precise Basecalling of Short-Read Nanopore Sequencing

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.12.612746

N/A

0DataRank · unranked

2 citations

Mei‐Juan Tu, Chengcheng Song, Ziyang Liu, Katherine K. Wang, Shuibing Chen +3 more

An Iterative Approach to Polish the Nanopore Sequencing Basecalling for Therapeutic RNA Quality Control

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.12.612711

N/A

0DataRank · unranked

0 citations

Mei‐Juan Tu, Ziyang Liu, Katherine K. Wang, Yinshan Fang, Ning Hao +6 more

Practical Pharmacokinetic–Pharmacodynamic Models in Oncology

Pharmaceutics(2025)10.3390/pharmaceutics17111452

N/A

0DataRank · unranked

5 citations

Mei‐Juan Tu, Ai‐Ming Yu, Su Guan

Impact of Posttranscriptional Modifications in Novel Bioengineered RNAs (Abstract ID: 163872)

Journal of Pharmacology and Experimental Therapeutics(2025)10.1016/j.jpet.2024.101682

N/A

0DataRank · unranked

0 citations

Mei‐Juan Tu, Ziyuan Wang, Patrick A. Limbach, Hongxu Ding, Ai‐Ming Yu +1 more

Production and use of recombinant mirnas to dissect the intrinsic differences in miRNA biogenesis and regulation of drug metabolism and disposition

Drug Metabolism and Pharmacokinetics(2025)10.1016/j.dmpk.2025.101337

N/A

0DataRank · unranked

0 citations

Yimei Wang, Ai‐Ming Yu, Neelu Batra, Mei‐Juan Tu

A reference-guided iterative approach to polish the nanopore sequencing basecalling for therapeutic RNA quality control

Communications Biology(2025)10.1038/s42003-025-08811-4

N/A

0DataRank · unranked

0 citations

Mei‐Juan Tu, Ziyang Liu, Katherine K. Wang, Yinshan Fang, Ning Hao +6 more